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Evaluating the state of the oculomotor system of a patient is one of the fundamental tests
done in neuro-ophthalmology. However, up to date, very few quantitative standardized
tests of eye movements’ quality exist, limiting this assessment to confrontational
tests reliant on subjective interpretation. Furthermore, quantitative tests relying on eye
movement properties, such as pursuit gain and saccade dynamics are often insufficient
to capture the complexity of the underlying disorders and are often (too) long and
tiring. In this study, we present SONDA (Standardized Oculomotor and Neurological
Disorder Assessment): this test is based on analyzing eye tracking recorded during a
short and intuitive continuous tracking task. We tested patients affected by Multiple
Sclerosis (MS) and Parkinson’s Disease (PD) and find that: (1) the saccadic dynamics of
the main sequence alone are not sufficient to separate patients from healthy controls;
(2) the combination of spatio-temporal and statistical properties of saccades and
saccadic dynamics enables an identification of oculomotor abnormalities in both MS
and PD patients. We conclude that SONDA constitutes a powerful screening tool that
allows an in-depth evaluation of (deviant) oculomotor behavior in a few minutes of
non-invasive testing.
Keywords: eye movement, assessment, Parkinson’s disease, multiple sclerosis, standardized, clinical, screening
INTRODUCTION
Eye movements are a fundamental component of vision. Their evaluation is an important aspect of
assessments in neurology and ophthalmology. Two neurological conditions in which oculomotor
assessment has great clinical relevance areMultiple Sclerosis (MS) and Parkinson’s Disease (PD). In
MS, the oculomotor assessment is relevant for diagnosis, for monitoring progress and for prognosis
(1–3), while in Parkinson’s Disease (PD), eye-movements can help in differentiating the “pure” form
of PD from other forms of parkinsonism (4–6).
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For both MS and PD, a confrontational assessment is the
most commonly used technique for evaluating patients’ eye
motility. While the simplicity of a confrontational assessment
is attractive, its qualitative and subjective nature may leave
subtle abnormalities undetected. In cases like sub-clinical
manifestations of internuclear ophthalmoplegia in MS, or in PD,
which typically exhibit eye movement disorders that are also
present in the healthy elderly population, quantitative approaches
are crucially needed (7).
At present, quantitative assessments are relatively sparse
and lack systematic, broadly accepted approaches. In
pathological conditions, the oculomotor performance is
usually parameterized using measures like the main-sequence
[i.e., the relationship between saccadic amplitude and peak
velocity (8, 9)], pursuit gain and onset latency, or generic
positional errors, measured discretely by repeating many trials
(10). These trial-based approaches are often complex, repetitive
and time-consuming, and—although being very suitable for
research [for a noticeable example see DEMoNS (11)]—they
cannot be easily translated into daily clinical practice. Stressing
the patients with such tests for longer than a few minutes can
also exacerbate their symptoms: MS patients, for instance, are
particularly affected by fatigue, which is reflected in changes in
their saccadic peak velocity (12).
If we were to have a fast and simple yet powerful assessment of
oculomotor quality, this could greatly benefit clinical practice. In
this study we introduce SONDA, a StandardizedOculomotor and
Neurological Disorders Assessment. This paradigm is partially
based on the eye-movement cross-correlogram (13) applied
to a continuous visual tracking task. This method measures
several spatio-temporal properties (STP) of eye movements while
patients track a moving dot with their eyes. In the analyses, the
eye movements and their STP can be related to various aspects of
visual functioning: e.g., the presence of visual field defects (14)
or spatial (15). The main advantage of this approach is that it
provides a broad range of oculomotor measurements in a time-
efficient and patient-friendly manner. Additionally, being able
to provide an in-depth characterization of multiple aspects of
eye movements is critical, because the clinical manifestations of
oculomotor abnormalities are complex and variegated.
In MS, inflammatory demyelinating lesions in different brain
areas result in a wide range of oculomotor disorders: most
commonly, static and dynamic ocular misalignment (16) coupled
with dysmetric saccadic behavior (17). Furthermore, fixation
(18), smooth pursuit (19), and vestibulo-ocular responses (20)
are also often impaired. Most of these disorders are accentuated
by the presence of internuclear ophthalmoplegia (INO). INO
is a neuro-ophthalmic condition present in approximately
one out of three MS patients (21) and is characterized by
impaired adduction of conjugate lateral eye movements. The
presence of INO is often determinant to confirm the diagnosis
of MS, especially if it is bilateral (22), but its sub-clinical
manifestations are difficult to identify without quantitative
approaches (23).
Parkinson’s Disease (PD) and other forms of parkinsonism
share some common features, such as saccadic intrusions and
square-wave jerks, but each clinical phenotype of parkinsonian
disorders has a distinctive profile of oculomotor impairments (4–
6). Eye-movement disorders typical of PD are impairment of self-
paced saccades, saccadic hypometria, and saccadic fragmentation
(24): all contribute to disrupting smooth pursuit as well,
due to the resulting inadequacy of catch-up saccades. These
disorders, with the exception of the impairment of self-paced
saccades, are also commonly present in otherwise healthy
elderly individuals (25). This implies that just finding an
abnormality in eye movements will be insufficient to disentangle
PD-related ones from those caused by normal aging, thus
highlighting the need for multidimensional analysis of the
oculomotor assessments.
We investigated whether the STP quantified with continuous
gaze tracking is a sufficiently sensitive measure of the oculomotor
disorders usually present in MS and PD. Furthermore, we
extended the continuous gaze tracking method in order to
measure saccadic dynamics continuously over time and to
extract their frequency distribution. This will provide both a
direct comparison between the eye-movement cross-correlogram
STP and the saccadic main-sequence, as well as allowing
the possibility of integrating these measurements into a
single assessment.
More specifically, we answer the following research question:
how well can the continuous gaze-tracking task of SONDA
identify oculomotor abnormalities associated with MS and PD?
To summarize our findings, in both MS and PD patients,
SONDA identified both marked and subtle abnormalities in
oculomotor behavior based on only a few minutes of non-
invasive testing. Therefore, we conclude that SONDA allows an
in-depth characterization of (deviant) oculomotor behavior and
thus constitutes a powerful screening tool.
METHODS
Observers
We assessed 71 participants divided into three groups. The first
group comprised 50 healthy controls (age range 30–79, mean
age 53 ± 13.7, 26 females). The second group comprised 12MS
patients (age range 40–76, mean age 54 ± 10.8, 8 females). The
third group comprised 9 PD patients (age range 59–77, mean
age 68 ± 6.8, 2 females). All observers but one control and one
MS patient had normal or corrected to normal visual acuity
(below or equal to 0.10 LogMAR). All control participants were
tested and screened with questionnaires to assess their familiarity
with neurological and ophthalmological disorders at Royal Dutch
Visio, Haren, The Netherlands. All observers gave their written
informed consent prior to participation. The study was approved
by the Medical Ethical Committee of the University Medical
Center Groningen and the Ethics Committee of Psychology of
the University of Groningen. The study followed the tenets of the
Declaration of Helsinki.
Apparatus
A “Tobii T60 XL” eye-tracker (Tobii Technology, Stockholm,
Sweden) was used to record the eye movements of the
observers. The recording was conducted binocularly, with a
sampling frequency of 60Hz. A custom-made 9-point calibration
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procedure was performed prior to each experimental session.
The calibration was repeated until the average error was below
1◦ of visual angle and the maximum error below 2.5◦. Stimuli
were generated using custom-made scripts inMATLAB using the
Psychophysics Toolbox (26, 27) and displayed on the integrated
screen of the Tobii T60 XL at a refresh rate of 60Hz and viewed
from a distance of 60 cm. Normally, this relatively low refresh
rate is less suitable for the study of saccade dynamics, but we
addressed this issue using a custom-made saccadic detection
algorithm (see “Eye-tracking data analysis” paragraph). Head
movements were minimized using a chin-rest with forehead
support. All data were analyzed with custom-made MATLAB
scripts (R2017b, Mathworks). All display and analysis code is
available upon request.
Continuous Tracking Task
The visual stimulus consists of a Gaussian blob of increased
luminance moving along a random-walk trajectory on a uniform
gray background (∼140 cd/m2). The Gaussian blob is displayed
at two contrast levels: at high contrast (50%) it has a peak
luminance of ∼385 cd/m2, while when presented at low contrast
(10%), it has a peak luminance of ∼160 cd/m2. Its full-width-at-
half-maximum is 0.83◦, roughly corresponding to the size III of a
Goldman perimeter’s stimulus.
There were two stimulus conditions: in the smooth pursuit
condition, the stimulus moved continuously along the random-
walk path, while in the saccadic pursuit condition, an additional
positional displacement to a random location on the screen was
added to the trajectory, that occurred every 2 s. Each observer
performed 6 trials of 20 s for each one of the conditions for a
total of 12 trials and 4min of total data acquisition. Short breaks
in between trials were allowed. Additional detail regarding the
visual stimulation can be found in Supplementary Material.
Eye-Tracking Data Analysis
The extraction of the oculomotor spatio-temporal features is
described in Supplementary Material.
Individual saccades were identified from the raw data using
a customized MATLAB implementation based on the algorithm
described by Behrens et al. (28). This algorithm allows saccade
identification in eye movement time series using an adaptive
threshold based on eye-movement acceleration. In short, the
algorithm classifies any given time point at which the eye
acceleration exceeds this adaptive threshold as being part of a
saccadic movement. In their paper, the authors computed the
threshold as a constant (K = 3.4) multiplied by the standard
deviation of the acceleration distribution within a moving
window of 200 frames, acquired at 1 kHz (i.e., a window of 0.2 s).
Our adapted version uses amoving window of 60 frames acquired
at 60Hz (i.e., a window of 1 s). Empirically, we found our variant
to be adequate for an accurate identification of saccades in our
experiment. In contrast to Beherens et al., we did not apply a
low-pass filter to the velocity signals.
Since we conducted the gaze recording binocularly, we applied
the saccade detection algorithm to the time series of each eye.
An example of the saccades detected for one eye during one
tracking trial is shown in Figure 1. Once the individual saccades
are identified, their amplitude, peak velocity, and direction
are computed. Next, we used these parameters to compute
the saccadic frequency and the saccadic dynamics distributions
as a function of visual field eccentricity and direction. To
determine whether the oculomotor behavior of patients differed
from normal, we computed normative values based on the
results of the control population. Because the age distribution
of PD and MS patients differed, we computed separate
normative values for each class of patients (see Results section,
Figures 5B,C, 6B,C).
Statistical Analysis
The results of the patients’ oculomotor behavior are expressed in





Where MED and MAD are the Median and Mean Absolute
Deviation in the age-matched normative control population
used as a reference. The individual saccades extracted with
the algorithm described in the previous section, are binned
in the function of their direction along the visual field, and
used to display the saccadic frequency distribution (examples in
Figures 5B, 6B) and the saccadic dynamics (amplitude and peak
velocity, examples in Figures 5C, 6C). Specifically, we treated
each saccade of each eye as a vector defined by the starting
point and ending point of the saccades, expressed in polar
coordinates. We computed the directions of the saccade vectors,
and then binned them in 12 main directions, resulting in a bin
size of 30◦.
For MS patients, the entire group of controls is used as
normative data, as their age distributions are very similar
(see Observers section). Since as a group the PD patients
were significantly older, for the age-matched normalization it
was necessary to create a subgroup of controls excluding all
participants under 50 years of age. To take into account the
different sizes of the groups (Ncontrols = 50, NMS = 12, NPD = 9),
the statistical comparison between patients and controls have
been performed using one-tailed Welch’s t-test for unequal
variances with α = 0.05.
The analysis of oculomotor spatio-temporal properties (STP)
resulted in 80 features (10 unique STP × 2 axis × 2
pursuit conditions × 2 eyes). See Supplementary Material
for a description of the individual spatio-temporal properties.
For the purposes of the clustering analysis, we did not
normalize the patients’ features with respect to the control
group. Prior to performing the clustering analysis, we reduced
the dimensionality of this dataset by employing a Principal
Component Analysis (PCA) with the goal of removing redundant
features. Based on the PCA, we identified the number
of components sufficient to explain at least 95% of the
variance. Following the PCA, we applied t-Distributed Stochastic
Neighbor Embedding (tSNE) on the remaining components.
This technique allows visualizing high-dimensional data by
modeling each high-dimensional object as a two- (or three-)
dimensional point in such a way that similar objects are
modeled as nearby points and dissimilar objects are modeled
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FIGURE 1 | (A) Example of a time series of eye movements’ positions recorded during a trial of 20 s of the tracking task. (B) Example of eye acceleration and the
value of the adaptive saccadic threshold for one eye plotted as a function of time. The adaptive threshold (in red) at any given time point is computed as the standard
deviation of acceleration distribution in the preceding 60 samples, multiplied by a constant (K = 3.4). Whenever acceleration exceeds the momentary threshold, the
time point is marked as being part of a saccade. (C) Back-projection of the time points marked as being part of a saccade onto the original time series of eye
positions (top figure showing the horizontal and the bottom figure showing the vertical component).
as more distant points. Lastly, to identify clusters amongst the
t-SNE points, we applied a k-means clustering algorithm. The
appropriate number of clusters k was chosen using the Elbow
Method (29) applied to the Within-clusters Sum of Squares
(WSS). Based on the resulting k, the location and size of each of
the clusters was computed.
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FIGURE 2 | Saccadic main-sequences in the three examined groups of observers. The individual saccades (scatter plot) display the classic exponential relationship
between amplitude and peak velocity, with no statistically significant differences between Control, MS, and PD groups: all 95% prediction intervals overlap with each
other. Also when taken separately (marginal histograms), the amplitude and peak velocity distributions do not differ between groups or between eyes.
RESULTS
To summarize our findings, we find that the main-sequence
alone is often insufficient to detect the presence of oculomotor
abnormalities in either MS or PD. In contrast, we find that
the STP obtained with our SONDA paradigm well separates
PD patients from healthy controls. The STP of MS patients are
insufficient to separate them from controls. Nevertheless, when
we combine the STP with saccadic dynamics and frequency
distributions, both PD and MS patients can be distinguished
from controls.
Main-Sequences of Saccades in PD and
MS Do Not Differ From Controls
First, we determined whether the oculomotor abnormalities of
PD and MS patients are reflected in changes in the measures
obtained with our continuous gaze-tracking task. Figure 2 shows
the main-sequence plots of amplitude vs. peak velocity for each
saccade made by every patient and control made during the
tracking task (algorithm described in Methods, Figure 1). We
found no differences at the group level: both the amplitude and
peak velocity distributions of the two patient groups overlap with
those of the control group. For all three groups tested, we find
an exponential relationship between amplitude and peak velocity.
This behavior is expected (8). The prediction intervals (95%) of
the patients’ group data overlap with those computed for the
control groups’ data.
Eye Movement Spatio-Temporal Properties
of PD and MS Compared to Normative
Data
Figure 3 shows the results of the analysis of the STP of eye
movements made in the continuous tracking task.
In MS patients (upper row), we find a substantial overlap
of their features with the normative ones. We can observe a
higher variability compared to controls and PD (lower row),
especially in the Smooth condition. Statistically significant
differences (indicated by an asterisk) are found for the temporal
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FIGURE 3 | Oculomotor spatio-temporal properties in MS and PD cohorts, compared to an age-matched normative baseline. For the spatio-temporal analysis of the
continuous gaze tracking task, we applied the eye-movement crosscorrelogram method (13, 14). From all features computed, we selected the two temporal and two
spatial features that were shown to be most strongly modulated by stimulus velocity (30). The selected features are: “lag” (F1), “temporal uncertainty” (F2), “error
spread” (F3), and “dissimilarity” (F4). “Lag” represents the delay between eyes and stimulus, measured as the temporal offset of the peak of the cross-correlation
between stimulus and eye velocities. “Temporal uncertainty” represents the consistency of the velocity of the eye in relation to the velocity of the stimulus. “Error
spread” is the standard deviation of the distribution of eye-stimulus positional deviations. “Dissimilarity” is the inverse of the cosine similarity computed between the
arrays of gaze coordinates and stimulus coordinates.
uncertainty and the movement dissimilarity features, but only
in the Saccadic condition, where participants had to make
saccades in order to track the rapid, random, displacements of
the target.
In PD patients (lower row), nearly all features are significantly
different from the normative ones. The magnitude and variance
of the differences are larger in the Saccadic condition, similar to
what we found in the MS patients.
For both MS and PD patients, there was neither significant
difference for the left and right eyes, nor for the horizontal and
vertical components of the eye movements.
Based on the amount of significantly deviating features,
our results indicate that, at the group level, MS patients
had abnormalities primarily during the saccadic pursuit, while
PD patients had abnormalities in both saccadic and smooth
pursuit conditions.
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FIGURE 4 | Results of STP-based clustering analysis for the entire tested population. (A) Principle Component Analysis (PCA): all the spatio-temporal features
available from SONDA (see Supplementary Material) were used as an input for the PCA. The resulting components were processed with t-SNE to represent the
high-dimensionality dataset into a lower-dimensionality space for clustering purposes. (B) Computation of the optimal number of clusters using the “elbow method”
with the Within-clusters Sum of Squares (WSS) as a parameter. (C) Result of the k-means clustering algorithm (k = 5) applied to the outcome components of t-SNE.
Classification of the Neurological Disorder
Based on Oculomotor Abnormalities
We examined whether it is possible to identify the underlying
neurological conditions of individual patients based exclusively
on the eye-movements measurement. The results are shown in
Figure 4. Of the 80 initial features (10 oculomotor properties× 2
axis × 2 pursuit conditions × 2 eyes), the PCA indicated that 11
components are sufficient to explain 95% of the variance in the
data (Figure 4A). We then used the t-SNE algorithm to embed
these 11 principal components into two final components for
clustering and visual representation. We found that the optimal
number of clusters to represent the data is five (Figure 4B).
The results of the k-mean analysis are shown in Figure 4C. The
leftmost cluster (1) contains nearly all PD patients and two of
the MS patients. Being most separated from the other clusters,
this cluster appears to group the cases with the most severe
oculomotor impairments. The rightmost cluster (2) includes the
vast majority of control subjects, thus grouping those without
an oculomotor impairment. It partially overlaps with clusters
(3) and (4) which contain participants from various groups and
together cover nearly all MS patients. These clusters, therefore,
appear to group patients with a suspected impairment of different
degrees of severity. The remaining cluster (5) comprises outliers
that, upon verification, were associated with very noisy data
and/or exceptionally poor performance. Altogether, these results
show that despite the relatively low number of subjects, a
classification based exclusively on STP is reasonably effective for
Parkinson’s Disease but ineffective for MS.
Combination of STP With Statistical and
Dynamic Properties of Saccades
Next, we explored whether taking into account the frequency
distribution of saccades and their dynamic properties as a
function of direction (i.e., visual field polar angle) in combination
with STP obtained from the saccadic pursuit condition, would
allow for a better characterization of the oculomotor disorders.
The results for the left and right eye are displayed separately.
Figures 5, 6 show the results for MS and PD groups,
respectively. At a group level, MS patients showed impaired STP
(Figure 5A), no significant difference in the saccadic frequency
distribution (Figure 5B) and significantly different amplitude
and velocity (Figures 5C,D), primarily along the horizontal axis.
Still at the group level, PD patients showed impaired STP
(Figure 6A), significantly reduced saccadic frequency along the
vertical axis (Figure 6B), and significantly different amplitude
and velocity (Figures 6C,D). Overall the PD group showed more
significant deviations from controls compared to the MS group.
We then performed the same analysis, but at the single
subject level. Figures 7, 8 show the results for three MS
and three PD patients, respectively, and two age-matched
control observers. From each patient group, we selected
three patients of interest that showed either mixed results
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FIGURE 5 | (A) MS and PD group analysis of normalized spatio-temporal properties. (B) Normalized saccadic frequency distribution as a function of direction. (C)
Normalized saccadic amplitude as a function of direction. (D) Normalized saccadic peak velocity as a function of direction. The results of the saccadic dynamics are
stratified per quartile. An asterisk indicates a significant difference between normative values obtained from the control group.
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FIGURE 6 | Same as Figure 5.
regarding the STP, the saccadic frequency and saccadic dynamics,
or that had an additional diagnosis (e.g., INO in addition
to MS).
Panel A shows part of the STP previously presented in
Figure 3. We present the features for the horizontal and
vertical components of the saccadic pursuit condition, which we
















































FIGURE 7 | An in-depth overview of the oculomotor performance of three MS patients, three PD patients, and two age-matched controls. (A) Normalized spatio-temporal properties (STP). We consider an STP
feature abnormal if its deviates 2 or more standard deviations from the normative value (indicated in green). (B) Normalized saccadic frequency distributions. (C) Normalized saccadic dynamics (amplitude and peak



































































































FIGURE 8 | Same as Figure 7. and significantly different amplitude and velocity (Figurxxe). Overall the PD group showed more significant deviations from controls compared to the MS group and significantly




















































Grillini et al. Standardized Oculomotor and Neuro-Ophthalmic Disorders Assessment
already showed to be the condition with the most significant
differences. Our results show that the STP and the saccadic
dynamics are not always in agreement and thus convey
different types of information that may be relevant for a
clinical interpretation. Patient MS#1 had been previously
diagnosed with internuclear ophthalmoplegia (INO) and
has severely impaired STP (Figure 7A), a dysmetric saccadic
behavior with reduced adduction frequency (Figure 7B),
and an abnormal range of saccadic amplitudes and peak
velocities of which both are hypermetric (Figure 7C).
Patient MS#2 has normal STP (Figure 7A), an anisotropic
saccadic frequency distribution skewed rightward and upward
binocularly (Figure 7B). The saccades made by both eyes
are in the normal velocity range, but their amplitude is
mildly hypermetric, especially along a near vertical and in
a horizontal rightward direction (Figure 7C). Patient MS#3
has moderately impaired STP (Figure 7A), a normal saccade
frequency distribution (Figure 7B), and hypermetric amplitude
of the vertical saccades, with a normal peak velocity for both
eyes (Figure 7C).
Patient PD#1 has impaired STP, with a strong oculomotor
lag in both horizontal and vertical components (Figure 8A),
while both their saccadic frequency distribution (Figure 8B)
and saccadic dynamics (Figure 8C) are within the normative
range. Patient PD#2 shows severely impaired STP (Figure 8A),
an unusual “diagonally skewed” saccadic frequency distribution
for both eyes (with the upward component slanted toward the
nasal side; Figure 8B) and the saccadic peak velocity within the
normative range and nearly perfect normal saccadic amplitude
(Figure 8C). Finally, patient PD#3 has normal STP (Figure 8A)
and shows saccadic frequency distributions that deviate from
normal (Figure 8B) and show slightly hypermetric vertical
amplitude of the diagonal saccades. The peak velocities for both
eyes were normal (Figure 8C).
DISCUSSION
The main contribution of the present study is the introduction
of a novel method to perform a time-efficient (<5min), non-
invasive, neuro-ophthalmic screening that is based on an in-
depth characterization of oculomotor behavior in response to a
simple visual tracking task.
First, our results indicate that the most commonly used
conventional measures, such as saccadic amplitude and peak
velocity by themselves, are often insufficient to fully characterize
the oculomotor behavior of PD and MS patients. Moreover, we
show that the computation of the spatio-temporal properties
(STP) of eye-movements recorded during a continuous tracking
task can help detect abnormalities in the oculomotor behavior.
Therefore, we conclude that a combination of improved
conventional (saccadic frequency distribution and dynamics)
and our entirely new spatio-temporal analyses are an effective
screening tool to comprehensively assess the oculomotor
behavior of a patient. The clinical relevance of this will be
discussed below for each class of patients.
SONDA Identifies Oculomotor
Abnormalities in Multiple Sclerosis
The parameters of the main-sequences—saccadic amplitude
and saccadic peak velocity—of MS patients showed an almost
identical distribution to those of the controls (see Figure 2).
This is consistent with the literature, which indicates that most
CNS lesions of this disease have not been associated with
unique identifiable clinical symptoms in eye-movements (2).
Thus far, the majority of the studies on oculomotor abnormalities
in MS patients focused on the detection of internuclear
ophthalmoplegia (INO). This disorder may be present (often
subclinically) in ∼30% of MS patients and is usually identified
by measuring the versional dysconjugacy index (VDI), which
is the ratio between abducting and adducting eye saccadic
dynamics (21, 31, 32). However, despite that relying on the main-
sequence parameters alone is insufficient, standardized screening
tests capable of detecting other manifestations of oculomotor
abnormalities in MS do not exist.
With our novel “SONDA” approach introduced in this study,
in MS we found preserved smooth pursuit responses and
two abnormal features in the saccadic pursuit condition (see
Figure 3). This is consistent with the notion that the most
common saccadic issue in MS is saccadic dysmetria (17), present
especially in patients with demyelination affecting the cerebellar
peduncles (33). However, given the relatively small sample (NMS
= 12) the significant difference seems to be driven mostly by
a few severely impaired patients, rather than a general decrease
in performance.
An interesting result emerged from the clustering analysis
shown in Figure 4. In this case, we performed a multivariate
analysis based on the whole feature-space of STPs obtained
with SONDA, rather than selecting a few parameters a priori.
We found that MS patients, although not well separable from
controls, nevertheless tended to cluster [clusters (3) and (4)]
based solely on their STPs. This suggests the presence of
subtle oculomotor abnormalities that require more detailed
quantification of the eye movements.
To further explore this hypothesis we also quantified per eye
the saccadic frequency and the saccadic dynamics distributions
in the function of direction (Figures 5–8).
These extended analyses revealed the presence of
abnormalities even in patients falling within the normative
STP ranges, or in the saccadic dynamic when taking into account
their directionality. While at a group level, few significant
deviations are detected (see Figures 5B–D), at the single subject
level taking into account the direction of the saccades can
aid in identifying the underlying oculomotor disorder. For
instance, patient MS#2 has a normal STP (Figure 7A), only
slightly abnormal saccadic dynamics (Figure 7C), but a very
peculiar saccadic frequency distribution (Figure 7B). This
latter analysis revealed an abnormal prevalence of horizontal
rightward saccades for both eyes. This is analogous to what
has been observed in pathological nystagmus: a slow-drift of
eccentric gaze in one direction followed by a resetting saccade
in the other, which is caused by a failure of the common
neural integrator of eye movements in the brainstem (2).
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While the other two MS patients (MS#1 and MS#3) have an
abnormal STP (Figure 7A). A further inspection of their saccadic
frequency distributions does differentiate between them: MS#3
has a normal saccadic frequency distribution (Figure 7B) and
only slightly hypermetric vertical saccades (Figure 7C). The
oculomotor abnormalities of patient MS#3 might have gone
unnoticed if the assessment had been limited to the saccadic
dynamics. On the other hand, besides an abnormal STP, patient
MS#1 also displays overall hypermetric saccades, as well as the
suppression of adducting saccades (Figure 7B) that is typical
of INO.
SONDA Identifies Oculomotor
Abnormalities in Parkinson’s Disease
In PD, slower saccades should be expected in advanced cases
(25, 34, 35). Yet, at the group level, the prediction intervals
for the saccadic main-sequence of the PD patients overlap
with those of the control group (see Figure 2). In contrast
a significant difference is found in all examined STP, except
for the spread of the positional error (Figure 3). Noticeably,
we found marked differences along the vertical axis of the
smooth pursuit condition for almost the entire group, although
mild cases of PD are expected to be similar to age-matched
control observers (25, 36). This can be due to the fact
that while unpredictable pursuit should be poor in PD, the
predictive component of pursuit is generally preserved (37).
However, our stimulus trajectory is completely unpredictable
(by design it does not contain any autocorrelation; see
Supplementary Material). This explains why our approach was
sensitive to PD related abnormalities.
Regarding saccades, one of the characteristic oculomotor
disorders in PD is the impairment of self-generated saccades
with the relative sparing of visually-driven saccades, which only
deteriorate as the disease progresses (10). In our tracking task
we tested only visually-driven saccades but still found significant
differences in the STP ofmost patients. This is important, because
at the single-subject level (Figure 8C) the saccadic dynamics of
the PD in some patients were remarkably normal. It suggests that
SONDA is a sensitive paradigm.
For the PD patients, the clustering analysis based on SONDA’s
STP resulted in the separation of most PD individuals from
the controls (Figure 4). This is quite remarkable considering
that, for pure Parkinson’s Disease (which all patients in our
group were) the eye movements usually only show minor
disturbances that are common in healthy elderly subjects
as well (10). Note that this contrasts with other forms of
parkinsonism. Furthermore, one of the main oculomotor
abnormalities in PD is the difficulty in generating internally
driven saccades. Most errors are made when PD patients
are required to switch between instructions [e.g., switching
between pro- and antisaccades (38–40)]. Such switching
is not demanded by our paradigm. Nonetheless, abnormal
oculomotor behavior could be clearly identified in all
PD patients.
An in-depth inspection of the oculomotor behavior that
takes into account the direction of saccades, revealed that at a
group level some significant deviations in amplitude and peak
velocity can be detected (Figures 6C,D). Further more the single-
subject analysis (Figure 8) showed that, analogously to MS, an
analysis of the saccadic frequency distribution can reveal subtle
abnormalities that other measures (STP and saccadic dynamics)
cannot (see Figure 8, PD#3 for an example). Nevertheless, in the
majority of the PD patients, the STP by itself was sufficient to
identify eye movement abnormality (as already revealed by the
clustering analysis).
SONDA Is Clinically Relevant
The SONDA paradigm allows for a comprehensive examination
of eye-movements that provides detailed information on the
dynamics and statistical properties of saccades, as well as
a novel set of spatio-temporal properties that quantify both
smooth and saccadic pursuit behavior. Given the large number
of parameters, our technique also opens up possibilities for
machine-learning-aided diagnosis of neuro-ophthalmic and
neurological impairment based on eye movements. We and
others have previously demonstrated the feasibility of such
an approach for identifying (simulated) ophthalmic disorders
(14, 41), and for neurological conditions [the latter based on
participants viewing natural scenes (42)]. Compared to other
high-throughput eye-tracking tests, SONDA has two main
advantages. First, excluding calibration (that is common for
all eye-tracking tests), the whole assessment takes only 4min
[compared to ∼20min for the approach of Tseng et al. (42)
and ∼25min for DEMoNS (11)]. Second, our task and stimulus
were designed to be as intuitive and simple as possible to avoid
confounding factors that may be caused by natural or more
complex stimuli, or complicated instructions resulting in a higher
cognitive load.
Future Applications
Objective, quantitative eye-movement-based tests are
increasingly becoming an important aid in diagnosing
and monitoring neuro-ophthalmic conditions of which the
oculomotor manifestations cannot always be clinically detected
with confrontational assessments (43). For instance, in some
patients oscillopsia occurs in conjunction with eye movements
that are too small to be detected using an ophthalmoscope, yet
that are large enough to cause visual complaints (44). Another
example of the use of eye-movement-based metrics is the
assessment of surgical or pharmacological interventions for
nystagmus (45, 46). Such disorders are rather common in MS
when lesions involve the brainstem and the cerebellum (2) and
can occur in PD as well, sometimes causing oscillopsia (47).
Besides MS and PD, the new parameters provided by SONDA
can be relevant in the evaluation of other neurological and
psychiatric disorders, such as mild traumatic brain injury (48),
schizophrenia (49), or dementia with Lewy bodies (50). In
these disorders, the parameters of the saccadic main-sequence
of patients often overlap with those of controls. For this reason,
outcomes cannot be considered definitively diagnostic (17). A
multi-dimensional characterization of oculomotor properties,
such as provided by SONDA, could thus also be beneficial in
these conditions.
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Limitations
Our present study still has some limitations that should be
addressed in future follow-up. First, the number of observers
tested in comparison to the number of features analyzed was
only just enough to use t-SNE and k-mean clustering (N = 71
observers and 11 PCA components; see Figure 4). Combined
with the imbalance within groups (Ncontrol = 50, NMS = 12,
NPD = 9) this may have prevented an optimal separation of
the MS patients from the controls. Another aspect that requires
further investigation is the sensitivity/specificity of the measures
that were expressed as a function of the visual field polar angle
(Figures 7B,C, 8B,C). The number of bins used to determine
the polar histograms was chosen arbitrarily and might affect the
false negative/positive rate depending on the data available in
each bin.
Conclusions
We presented SONDA, a novel paradigm to assess oculomotor
abnormalities that can be linked to neurological disorders. We
tested patients affected by Multiple Sclerosis and Parkinson’s
Disease and showed that: (1) the parameters of the saccadic
main-sequence alone are insufficient to separate patients from
healthy controls; (2) spatio-temporal and statistical properties
of the eye movements obtained with SONDA, when combined
with detailed analysis of saccadic dynamics allow for a correct
identification of the oculomotor abnormalities and a possible
identification of the underlying neurological disorder. Our
test constitutes an attractive approach for quantitative neuro-
ophthalmic screening, being non-invasive, intuitive and fast
to administer.
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